Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fehm

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|August 16, 2012
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trialI Witzel, S Loibl, G von Minckwitz, et al.
Plos One|June 7, 2017
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trialB A S Jaeger, J Neugebauer, U Andergassen, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Hormone Therapy and its Effect on the Prognosis in Breast Cancer PatientsC Rauh, F Schuetz, B Rack, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2017
Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A StudyA Hein, B Rack, L Li, et al.
Geburtshilfe Und Frauenheilkunde|September 2, 2016
The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and PatientsS Burghaus, T Fehm, P A Fasching, et al.
BMJ Open|December 1, 2020
Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trialEvelyn Annegret Huhn, Tina Linder, Daniel Eppel, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
Der Pathologe|May 20, 2015
[Neuroendocrine neoplasms of the breast]M Anlauf, M Neumann, S Bomberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|August 16, 2012
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trialI Witzel, S Loibl, G von Minckwitz, et al.
Plos One|June 7, 2017
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trialB A S Jaeger, J Neugebauer, U Andergassen, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Hormone Therapy and its Effect on the Prognosis in Breast Cancer PatientsC Rauh, F Schuetz, B Rack, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2017
Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A StudyA Hein, B Rack, L Li, et al.
Geburtshilfe Und Frauenheilkunde|September 2, 2016
The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and PatientsS Burghaus, T Fehm, P A Fasching, et al.
BMJ Open|December 1, 2020
Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trialEvelyn Annegret Huhn, Tina Linder, Daniel Eppel, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
Der Pathologe|May 20, 2015
[Neuroendocrine neoplasms of the breast]M Anlauf, M Neumann, S Bomberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Pageof 10